|
Median antifilarial IgG levels for the 126 persons in the Mapou cohort who received antifilarial drug treatment in 2000 and the 34 who did not, by year |
||||
| Antifilarial Antibody Level* |
||||
| Treatment status |
2000 |
2001 |
||
| Received treatment |
Median (interquartile range) |
Median (interquartile range) |
p-value |
|
|
|
||||
| IgG1 |
68.5 (22.2–147.5) |
43.0 (20.9–85.6) |
0.001 |
|
| IgG4 |
57.5 (29.9–98.3) |
55.9 (21.0–65.9) |
0.067 |
|
| Did not receive treatment |
||||
| IgG1 |
64.5 (31.9–157.0) |
100.0 (52.3–169.7) |
0.101 |
|
| IgG4 |
61.5 (45.6–104.6) |
96.4 (52.40–216.0) |
0.088 |
|
|
*units | ||||
Washington et al. Filaria Journal 2004 3:3 doi:10.1186/1475-2883-3-3 |
||||